Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs12312782 | chr12:107135647 | G/A | 0.000113 | 133 | 42.27 | 45.1 | 28.8 | KM Plot |
| TGCT | rs12321643 | chr12:129302867 | A/T | 1.39E-5 | 134 | 41.33 | 44.28 | 29.53 | KM Plot |
| TGCT | rs12321679 | chr12:129284791 | G/A | 1.39E-5 | 134 | 41.33 | 44.28 | 29.53 | KM Plot |
| TGCT | rs12333241 | chr6:42671439 | G/A | 4.06E-6 | 129 | 40.08 | 51.67 | 23.82 | KM Plot |
| TGCT | rs12410079 | chr1:65611399 | T/C | 0 | 128 | 45.7 | 28.8 | 0.57 | KM Plot |
| TGCT | rs12413577 | chr10:27588303 | C/T | 0 | 127 | 42.27 | 43.2 | 18.85 | KM Plot |
| TGCT | rs12414089 | chr10:27584269 | C/T | 0 | 127 | 42.18 | 45.83 | 18.85 | KM Plot |
| TGCT | rs12421762 | chr11:67373669 | G/T | 0.000122 | 134 | 42.18 | 39.38 | 62.58 | KM Plot |
| TGCT | rs12444630 | chr16:27814198 | A/G | 1.34E-5 | 130 | 42.1 | 44.05 | 17.27 | KM Plot |
| TGCT | rs12445660 | chr16:27808615 | A/G | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs12448720 | chr16:27808626 | T/C | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs12463484 | chr2:54757604 | T/A | 0.00012 | 134 | 45.7 | 44.05 | 18.57 | KM Plot |
| TGCT | rs12467653 | chr2:54840760 | C/T | 7.58E-5 | 130 | 45.1 | 42.27 | 22.42 | KM Plot |
| TGCT | rs12473338 | chr2:54838553 | A/G | 6.89E-5 | 131 | 45.1 | 44.05 | 22.42 | KM Plot |
| TGCT | rs12475598 | chr2:54840326 | A/G | 7.53E-5 | 130 | 45.7 | 42.12 | 22.42 | KM Plot |